Suvretta Capital Management, LLC Guardant Health, Inc. Transaction History

Suvretta Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$109.77 - $165.68 $61.7 Million - $93.1 Million	-561,690 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $6.09 Million - $8.58 Million	-47,912 Reduced 7.86%	561,690 $85.7 Million
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $15.9 Million - $21.6 Million	158,882 Added 35.25%	609,602 $78.6 Million
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $36.2 Million - $50.4 Million	450,720 New	450,720 $50.4 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.